India’s first mRNA-based Covid 19 vaccine has been cleared for further trials by the Drugs Controller General of India and will now undergo Phase II/III studies. Pune-based Gennova Biopharmaceutical’s is developing the homegrown vaccine in partnership with the Department of Biotechnology.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now